GP-Act III Acquisition Corp. Class A Ordinary Share Market Cap ($177.29 Million)
Market Cap & Net Worth: GP-Act III Acquisition Corp. Class A Ordinary Share (GPAT)
GP-Act III Acquisition Corp. Class A Ordinary Share market cap. GP-Act III Acquisition Corp. Class A Ordinary Share (NASDAQ:GPAT) has a market capitalization of $177.29 Million ($177.29 Million) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16810 globally and #4006 in its home market, demonstrating a 0.82% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GP-Act III Acquisition Corp. Class A Ordinary Share's stock price $11.10 by its total outstanding shares 16161228 (16.16 Million). Also see cash flow conversion of GP-Act III Acquisition Corp. Class A Ord for how efficiently the company converts equity into cash flow.
GP-Act III Acquisition Corp. Class A Ordinary Share Market Cap History (2024–2026)
GP-Act III Acquisition Corp. Class A Ordinary Share market cap history from 2024 to 2026. Data shows growth from $163.87 Million to $179.39 Million (4.63% CAGR). Check GPAT live share price for real-time trading data and today's change.
Index Memberships
GP-Act III Acquisition Corp. Class A Ordinary Share is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$40.09 Trillion | 0.00% | #1650 of 3165 |
Weight: GP-Act III Acquisition Corp. Class A Ordinary Share's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
GP-Act III Acquisition Corp. Class A Ordinary Share Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GP-Act III Acquisition Corp. Class A Ordinary Share's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore GPAT net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of GPAT by Market Capitalization
Companies near GP-Act III Acquisition Corp. Class A Ordinary Share in the global market cap rankings as of November 1, 2026. Also see GP-Act III Acquisition Corp. Class A Ord balance sheet assets for a full breakdown of the balance sheet.
Key companies related to GP-Act III Acquisition Corp. Class A Ordinary Share by market ranking:
- Twenty One Capital, Inc. (NYSE:XXI): Ranked #6082 globally with a market cap of $1.90 Billion USD.
- Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ:DMII): Ranked #10570 globally with a market cap of $647.19 Million USD.
- Ares Acquisition Corporation II (NYSE:AACT): Ranked #11034 globally with a market cap of $587.05 Million USD.
- Voyager Acquisition Corp (NASDAQ:VACH): Ranked #11434 globally with a market cap of $541.25 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #6082 | Twenty One Capital, Inc. | NYSE:XXI | $1.90 Billion | $5.48 |
| #10570 | Drugs Made In America Acquisition II Corp. Ordinary Shares | NASDAQ:DMII | $647.19 Million | $10.20 |
| #11034 | Ares Acquisition Corporation II | NYSE:AACT | $587.05 Million | $9.49 |
| #11434 | Voyager Acquisition Corp | NASDAQ:VACH | $541.25 Million | $24.79 |
Market Capitalization of GP-Act III Acquisition Corp. Class A Ordinary Share (2024–2026)
Market capitalization of GP-Act III Acquisition Corp. Class A Ordinary Share from 2024 to today. Between 2024 and today, GP-Act III Acquisition Corp. Class A Ordinary Share's market cap moved from $163.87 Million to $ 179.39 Million, with a yearly change of 4.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $179.39 Million | +3.84% |
| 2025 | $172.76 Million | +5.42% |
| 2024 | $163.87 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 1st, 2026 the market cap of GP-Act III Acquisition Corp. Class A Ordinary Share was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $177.29 Million USD |
| MoneyControl | $177.29 Million USD |
| MarketWatch | $177.29 Million USD |
| marketcap.company | $177.29 Million USD |
| Reuters | $177.29 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About GP-Act III Acquisition Corp. Class A Ordinary Share
GP-Act III Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp. in November 2020. GP-Act III Acquisition Corp. … Read more